The Effect of Insect Protein on Performance and Hypertrophy

The Effect of Insect Protein on Performance and Hypertrophy During Eight Weeks of Resistance Training

Purpose: to study the effect of insect protein on performance and hypertrophy during 8 weeks of resistance training.

Hypothesis: Insect protein supplementation enhances the effect of resistance training on muscle mass and muscle strength.

Primary outcome: Muscle hypertrophy and muscle strength

Design: Two groups of healthy young men (age: 18-30 years) with resistance training experience, but no structural resistance training performed for the last 12 months. Randomized controlled intervention study +/- insect protein (placebo group ingest isocaloric carbohydrate). Both groups perform 8 weeks of progressive resistance training (4/week) aiming to induce muscle hypertrophy.

Study Overview

• Status: Completed
• Conditions: Protein Supplementation
• Intervention / Treatment: Dietary supplement: Protein supplementation; Other: Resistance training

• Study Type: Interventional
• Enrollment (Actual): 18
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Denmark
  • Aarhus, Denmark, 8000
    • Aarhus University, Department for Public Health, Section for Sport Science

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 30 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

Description

Inclusion Criteria:

• Healthy young men (age: 18-30 years) with experience in resistance training
• 2 hours of physical exercise per week or more

Exclusion Criteria:

• No structural resistance training for the last 12 months
• No injuries
• No smoking
• No ingesting of protein or creating supplementations
• No use of medicine which may influence the adaptation to strength training

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Insect protein group; Exercise + insect protein 8 weeks of 4/week progressive resistance training (2 days upper body, 2 days lower body). Insect protein supplementation (4g/kg) after each training + before sleep at training days, and once in the morning at non training days.	Dietary supplement: Protein supplementation; + insect protein; Other: Resistance training; Resistance exercise
Placebo Comparator: Placebo group; Exercise + isocaloric carbohydrate 8 weeks of 4/week progressive resistance training (2 days upper body, 2 days lower body). Carbohydrate supplementation (isocaloric to protein group) after each training + before sleep at training days, and once in the morning at non training days.	Other: Resistance training; Resistance exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Muscle hypertrophy	muscle mass measured by DXA-scan	8 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Muscle Strength	muscle strength measured by maximal isometric muscle strength, 1RM at bench press and leg press and 80% 1RM to fatigue in bech and leg press	8 weeks

Collaborators and Investigators

• Sponsor: University of Aarhus

Study record dates

Study Major Dates

• Study Start (Actual): March 20, 2017
• Primary Completion (Actual): May 1, 2017
• Study Completion (Actual): May 1, 2017

Study Registration Dates

• First Submitted: January 23, 2017
• First Submitted That Met QC Criteria: January 25, 2017
• First Posted (Estimate): January 27, 2017

Study Record Updates

• Last Update Posted (Actual): May 9, 2017
• Last Update Submitted That Met QC Criteria: May 8, 2017
• Last Verified: January 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathological Conditions, Anatomical; Hypertrophy
• Other Study ID Numbers: Insect2017

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No